OYSTER PT PHARMA INC's ticker is OYST and the CUSIP is 69242L106. A total of 69 filers reported holding OYSTER PT PHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $275,000 | +29.7% | 48,934 | 0.0% | 0.00% | – |
| Q2 2022 | $212,000 | -91.0% | 48,934 | -75.7% | 0.00% | – |
| Q1 2022 | $2,346,000 | -21.3% | 201,569 | +23.4% | 0.00% | – |
| Q4 2021 | $2,982,000 | +54.7% | 163,328 | +0.4% | 0.00% | – |
| Q3 2021 | $1,928,000 | -19.9% | 162,706 | +16.1% | 0.00% | – |
| Q2 2021 | $2,408,000 | +21.9% | 140,107 | +29.7% | 0.00% | – |
| Q1 2021 | $1,975,000 | -5.4% | 108,033 | -2.6% | 0.00% | – |
| Q4 2020 | $2,088,000 | -3.2% | 110,956 | +8.6% | 0.00% | – |
| Q3 2020 | $2,156,000 | -22.2% | 102,132 | +6.4% | 0.00% | – |
| Q2 2020 | $2,772,000 | -16.2% | 95,971 | +1.6% | 0.00% | – |
| Q1 2020 | $3,306,000 | +218.8% | 94,453 | +122.6% | 0.00% | – |
| Q4 2019 | $1,037,000 | – | 42,430 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 2,768,586 | $32,226,000 | 14.34% |
| Paradigm Biocapital Advisors LP | 987,698 | $11,497,000 | 3.04% |
| NEA Management Company, LLC | 5,925,287 | $68,970,000 | 1.99% |
| KPCB XIV Associates, LLC | 367,987 | $4,283,000 | 1.61% |
| Telemark Asset Management, LLC | 787,026 | $9,161,000 | 0.81% |
| COWEN AND COMPANY, LLC | 509,794 | $5,934,000 | 0.57% |
| RTW INVESTMENTS, LP | 2,058,504 | $23,961,000 | 0.50% |
| ACT CAPITAL MANAGEMENT, LLC | 13,500 | $157,000 | 0.17% |
| Kohlberg Kravis Roberts & Co. L.P. | 1,039,622 | $12,101,000 | 0.11% |
| Wildcat Capital Management, LLC | 36,847 | $429,000 | 0.11% |